The Clorox Company $CLX Shares Bought by Bank of New York Mellon Corp

Bank of New York Mellon Corp grew its position in shares of The Clorox Company (NYSE:CLX) by 31.8% during the 4th quarter, Holdings Channel reports. The firm owned 1,251,045 shares of the company’s stock after purchasing an additional 301,624 shares during the period. Bank of New York Mellon Corp’s holdings in Clorox were worth $126,143,000 at the end of the most recent reporting period.

Several other hedge funds have also modified their holdings of CLX. BNP Paribas acquired a new stake in Clorox during the 4th quarter worth about $514,000. Peapack Gladstone Financial Corp raised its holdings in Clorox by 7.6% during the 4th quarter. Peapack Gladstone Financial Corp now owns 30,427 shares of the company’s stock worth $3,068,000 after buying an additional 2,144 shares during the period. Waterloo Capital L.P. grew its holdings in shares of Clorox by 156.6% during the fourth quarter. Waterloo Capital L.P. now owns 4,606 shares of the company’s stock valued at $464,000 after buying an additional 2,811 shares in the last quarter. Nomura Asset Management Co. Ltd. grew its holdings in shares of Clorox by 4.7% during the fourth quarter. Nomura Asset Management Co. Ltd. now owns 372,357 shares of the company’s stock valued at $37,545,000 after buying an additional 16,852 shares in the last quarter. Finally, MUFG Securities EMEA plc grew its holdings in shares of Clorox by 114.4% during the fourth quarter. MUFG Securities EMEA plc now owns 5,020 shares of the company’s stock valued at $506,000 after buying an additional 2,679 shares in the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Transactions at Clorox

In other news, Director Pierre R. Breber purchased 5,000 shares of the stock in a transaction that occurred on Tuesday, May 5th. The shares were purchased at an average cost of $85.82 per share, for a total transaction of $429,100.00. Following the completion of the purchase, the director directly owned 18,000 shares of the company’s stock, valued at approximately $1,544,760. The trade was a 38.46% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. 0.63% of the stock is owned by corporate insiders.

Analyst Upgrades and Downgrades

A number of research analysts have recently weighed in on CLX shares. Rothschild & Co Redburn set a $117.00 price target on Clorox in a report on Friday, February 13th. Wells Fargo & Company lowered their price target on Clorox from $100.00 to $95.00 and set an “equal weight” rating on the stock in a report on Monday, May 18th. Wall Street Zen raised Clorox from a “sell” rating to a “hold” rating in a research report on Saturday, February 7th. Zacks Research cut Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, May 12th. Finally, Jefferies Financial Group reduced their price objective on Clorox from $139.00 to $125.00 and set a “buy” rating for the company in a research report on Monday, May 4th. One analyst has rated the stock with a Buy rating, eleven have assigned a Hold rating and five have given a Sell rating to the stock. According to MarketBeat, the company presently has an average rating of “Reduce” and an average price target of $103.40.

Clorox Price Performance

NYSE CLX opened at $94.07 on Friday. The Clorox Company has a twelve month low of $84.70 and a twelve month high of $132.03. The company has a debt-to-equity ratio of 27.03, a quick ratio of 0.65 and a current ratio of 0.84. The stock has a market capitalization of $11.37 billion, a PE ratio of 15.27, a P/E/G ratio of 0.49 and a beta of 0.56. The stock has a 50-day simple moving average of $96.95 and a 200 day simple moving average of $105.31.

Clorox (NYSE:CLX) last posted its quarterly earnings data on Thursday, April 30th. The company reported $1.64 earnings per share for the quarter, topping the consensus estimate of $1.55 by $0.09. Clorox had a return on equity of 443.64% and a net margin of 11.18%.The business had revenue of $1.67 billion during the quarter, compared to analysts’ expectations of $1.67 billion. During the same quarter in the previous year, the firm earned $1.45 EPS. The firm’s revenue was up .1% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.450-5.650 EPS. Research analysts anticipate that The Clorox Company will post 5.61 EPS for the current year.

About Clorox

The Clorox Company is a leading manufacturer and marketer of consumer and professional products designed to help people care for their homes and live healthy, sustainable lives. Its portfolio spans cleaning and household products, food and beverages, water filtration systems and cat litter, serving both retail and institutional customers. The company’s flagship bleach and disinfecting products are well known in the United States and many international markets, where they help prevent the spread of germs in homes, hospitals, schools and businesses.

Clorox’s diverse brand lineup includes liquid bleach and surface cleaners, eco-friendly cleaning tools, food preservation and preparation items, charcoal grills and briquettes, specialty foods and beverages, pet care products and personal care lines.